These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 281566

  • 1. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR, Salomon JC.
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [Abstract] [Full Text] [Related]

  • 2. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD, Sedlacek R, Wagner M, Orsi L, Silobrcic V, Rothman KJ.
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [Abstract] [Full Text] [Related]

  • 3. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.
    Milas L, Hunter B, Mason K, Grdina D, Withers H.
    J Natl Cancer Inst; 1975 Apr; 54(4):895-902. PubMed ID: 1127718
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of the thermal response of animal tumors by Corynebacterium parvum.
    Urano M, Suit HD, Dunn P, Lansdale T, Sedlacek RS.
    Cancer Res; 1979 Sep; 39(9):3454-7. PubMed ID: 476675
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proposals for quality control methods of bacterial vaccines for immunostimulation. III. Effect of BCG and C. parvum on in vivo Listeria clearance and tumor growth.
    Ruitenberg EJ, Steerenberg PA, van Noorle Jansen LM.
    Dev Biol Stand; 1979 Sep; 38():97-101. PubMed ID: 415924
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma.
    Bast RC, Zbar B, Mackaness GB, Rapp HJ.
    J Natl Cancer Inst; 1975 Mar; 54(3):749-56. PubMed ID: 804566
    [Abstract] [Full Text] [Related]

  • 11. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT, Milas L.
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
    Urano M, Yamashita T, Suit HD, Gerweck LE.
    Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
    [Abstract] [Full Text] [Related]

  • 13. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW, Bartlett GL, Purnell DM, Webb S.
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
    Fisher B, Gebhardt M, Linta J, Saffer E.
    Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I, Scott AW, Halbherr T.
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [Abstract] [Full Text] [Related]

  • 16. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F, Stuart OA, Glehen O, Urano M, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [Abstract] [Full Text] [Related]

  • 17. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ, Mulé JJ, Rosenberg SA.
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [Abstract] [Full Text] [Related]

  • 18. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984 Oct; 32(4):405-12. PubMed ID: 6549499
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of Corynebacterium parvum extracts.
    McBride WH, Dawes J, Tuach S.
    J Natl Cancer Inst; 1976 Feb; 56(2):437-9. PubMed ID: 1255777
    [Abstract] [Full Text] [Related]

  • 20. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L, McGowan P, Ashe S, Johnston JV, Hellström I, Hellström KE.
    Cancer Res; 1994 Oct 15; 54(20):5420-3. PubMed ID: 7522958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.